ABORTION PILL
Abstract
Background. This contribution describes the history of the abortion pill, its introduction in the world and in our country. On the basis of the findings of the studies, carried out since the early ’80s, the authors provide the indications and contraindications for the application of the method.
Conclusions. The most efficient method for termination of an early pregnancy with least adverse side effects is the combination of drugs, viz. 1 tablet of mifepristone (200 mg) administered orally and 4 tablets (4 × 200 mcg) of misoprostol applied vaginally.
Downloads
References
Sitruk-Ware R. Approval of mifepristone (RU 486) in Europe. Zentralbl Gynekol 2000; 122: 241–7.
Karim SMM. Once a month vaginal administration of prostaglandin E2 in F2α for fertility control. Contraception 1971; 3: 173–83.
Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, Baulieu EE. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992; 71: 278–83.
Bartley J et al. Parity is a major detreminant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000; 62: 297–303.
Bygdeman M, Danielsson KG, Marions L. Medical termination of early pregnancy: the Swedish experience. J Am Med Womens Assoc 2000; 55: Suppl 3: 195–6, 204–4.
Creinin MD. Medical abortion regimens: Historical context and overview. Am J Obstet Gynecol 2000; 183: S3–S9.
Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: Efficacy and early medical sequelae. Hum Reprod 1994; 9: 2167–72.
Takkar D, Agarwal N, Sehgal R, Buckshee K. Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin. Adv Contracept 1999; 15: 163–73.
Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509–13.
Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract 1997; 44: 353–60.
Aubeny E, Peyron R, Turpin CL et al. Termination of early pregnancy (up to 63 days of amenorrhes) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995; 40: Suppl 2: 85–91.
World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. Br Med J 1993; 307: 532–7.
Ashok PW, Penney GC, Flett GMM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998; 13: 2962–5.
McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993; 8: 1502–5.
El Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception 1994; 49; 11–4.
El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Eng J Med 1995; 332: 983–7.
Andolšek L, Pretnar A. Prekinitev nosečnosti z mifepristonom. In: Pajntar M, Trenkić M eds. Prvi kongres ginekologov in perinatologov Slovenije z mednarodno udeležbo. Zbornik prispevkov, 1996, oktober 20-23; Portorož. Ljubljana: Slovensko zdravniško društvo, Ginekološka sekcija, 1996: 225–5.
Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vaccum aspiration. J Am Med Womens Assoc 2000; 55: Suppl 3: 141–4.
Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol 2000; 183: S44–S53.
Pohls UG, Steck T, Dietl J. Fetal complications associated with unsuccessful attempts at termination of pregnancy. Z Geburtshilfe Neonatol 2000; 204: 153–7.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
